Beam Therapeutics has presented the first clinical data on its base editing technology. | Beam Therapeutics has presented the ...

BEAM-101 seems to be competitive with approved sickle cell treatments, William Blair analysts said in a note to investors, ...

The patient died four months after BEAM-101 infusion “due to respiratory failure that was determined by the investigator to ...

The death, which investigators linked to a preparatory chemo treatment rather than Beam's medicine, highlights the risks of ...

BEAM-101 is an ex vivo genetic therapy delivered as part of an autologous haematopoietic stem cell transplant (HSCT) after a ...

Beam Therapeutics enrolls 35 patients in BEACON trial for BEAM-101 in sickle cell disease, with promising early safety and ...

Veterans Day 2024 has revived interest in what was at one time Gerstner Field, one of the largest of the 28 Aviation Signal ...

Analysts estimate that Beam Therapeutics will report an earnings per share (EPS) of $-1.16. The announcement from Beam Therapeutics is eagerly anticipated, with investors seeking news of surpassing ...

A tornado swept through their neighborhood. Once it passed, they thought the worst of it was over, only to step outside and ...

To accelerate its production, Israel recently invested over USD 500 million in contracts with local defense companies, Rafael ...

Israeli officials describe the Iron Beam system as being designed to work in tandem with existing air defense platforms such ...

The company Haiku Houses designed the post-and-beam structure reminiscent of a 16th century Japanese country house.